Close

More on DYAX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (3.3 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DYAX Cash Flow Statement

Click line-items for a historical chart and %
Cash flows from operating activities:
Net loss -27.38M
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of purchased premium/discount 795K
Depreciation and amortization of fixed assets and intangible assets 745K
Non-cash interest expense 0
Compensation expenses associated with stock-based compensation plans 13.6M
Loss on disposal of fixed assets
Provision for doubtful accounts
Changes in operating assets and liabilities:
Accounts receivable -450K
Prepaid research and development and other current assets
Inventory -7.2M
Other long-term assets
Accounts payable and accrued expenses 4.04M
Deferred revenue -1.22M
Long-term deferred rent
Other long-term liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of investments -236.16M
Proceeds from maturity of investments 208.98M
Purchase of fixed assets -1.33M
Proceeds from sale of fixed assets
Restricted cash
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Net proceeds from common stock offerings 229.77M
Repayment of long-term obligations -75.72M
Proceeds from the issuance of common stock under employee stock purchase plan and exercise of stock options 6.53M
Net cash provided by (used in) financing activities
Net increase (decrease) in cash and cash equivalents 97.3M
Cash and cash equivalents at beginning of the period 19.39M
Cash and cash equivalents at end of the period 116.69M
Supplemental disclosure of cash flow information:
Interest paid 7.69M